Q 32 Bio Inc (QTTB)

Feb 04, 2025

Q32 Bio to Participate in Oppenheimer's 35th Annual Healthcare Life Sciences Conference - The Eastern Progress Online

Feb 04, 2025

Feb 04, 2025

QTTB stock touches 52-week low at $2.95 amid market challenges - MSN

Feb 04, 2025

Jan 18, 2025

Barclays PLC Acquires 5,353 Shares of Q32 Bio Inc. (NASDAQ:QTTB) - Defense World

Jan 18, 2025

Jan 17, 2025

Q32 Bio Inc. (NASDAQ:QTTB) Receives $29.86 Consensus Target Price from Brokerages - Defense World

Jan 17, 2025

Jan 13, 2025

Q32 Bio Advances Clinical Trials for Growth Opportunities - TipRanks

Jan 13, 2025

Jan 12, 2025

Pre-market Movers: ONCO, EYEN, SGMO, VSTM... - RTTNews

Jan 12, 2025

Jan 11, 2025

Q32 Bio Inc (QTTB) Could Be Worth Considering For The Next Few Weeks - Stocks Register

Jan 11, 2025

Jan 11, 2025

Arq Inc (ARQ) Analyst Thoughts: How High Can It Go? - Stocks Register

Jan 11, 2025

Jan 11, 2025

Analysts Update Their Estimates For Brunswick Corp - Stocks Register

Jan 11, 2025

Jan 11, 2025

At $1.81 Price, XCHG Ltd ADR (XCH) Is Sitting And Waiting - Stocks Register

Jan 11, 2025

Jan 11, 2025

Analysts Update Their Estimates For EPR Properties - Stocks Register

Jan 11, 2025

Jan 11, 2025

Protagenic Therapeutics Inc’s (PTIX) -12.44% Retreat Justifies A Second Look - Stocks Register

Jan 11, 2025

Jan 11, 2025

LegalZoom.com Inc (LZ) Volatility Hits 3.83% – Here Is What You Should Do - Stocks Register

Jan 11, 2025

Jan 11, 2025

At $18.67 Price, Osisko Gold Royalties Ltd (OR) Is Sitting And Waiting - Stocks Register

Jan 11, 2025

Jan 11, 2025

First Foundation Inc (FFWM): A New Perspective - Stocks Register

Jan 11, 2025

Jan 11, 2025

Analyst Updating Price Targets And Ratings For Springview Holdings Ltd (SPHL) - Stocks Register

Jan 11, 2025

Jan 10, 2025

QTTB Stock Touches 52-Week Low at $3 Amid Market Challenges - Investing.com India

Jan 10, 2025

Jan 10, 2025

QTTB Stock Touches 52-Week Low at $3 Amid Market Challenges By Investing.com - Investing.com South Africa

Jan 10, 2025

Jan 07, 2025

What You Didn’t Know About Chipotle Mexican Grill (NYSE: CMG) This Week - Stocks Register

Jan 07, 2025

Jan 07, 2025

Q32 Bio (QTTB) Upgraded to Buy: What Does It Mean for the Stock? - MSN

Jan 07, 2025

Jan 07, 2025

Pre-market Movers: CDT, NARI, GDTC, NARI... - RTTNews

Jan 07, 2025

Jan 05, 2025

Geode Capital Management LLC Purchases 24,114 Shares of Q32 Bio Inc. (NASDAQ:QTTB) - Defense World

Jan 05, 2025

Jan 03, 2025

Jane Street Group LLC Acquires New Stake in Q32 Bio Inc. (NASDAQ:QTTB) - Defense World

Jan 03, 2025

Jan 03, 2025

Q32 Bio Inc. (NASDAQ:QTTB) Holdings Increased by Barclays PLC - Defense World

Jan 03, 2025

Jan 02, 2025

Franklin Resources Inc. Takes Position in Q32 Bio Inc. (NASDAQ:QTTB) - Defense World

Jan 02, 2025

Jan 02, 2025

NuScale Power Corporation (NYSE: SMR): An Enticing Stock To Watch - Stocks Register

Jan 02, 2025

Dec 30, 2024

Q32 Bio Inc. (NASDAQ:QTTB) Shares Bought by State Street Corp - Defense World

Dec 30, 2024

Dec 24, 2024

ARS Pharmaceuticals (NASDAQ:SPRY) vs. Q32 Bio (NASDAQ:QTTB) Head to Head Review - Defense World

Dec 24, 2024

Dec 23, 2024

Q32 Bio Inc. (NASDAQ:QTTB) Receives $29.86 Consensus Target Price from Analysts - Defense World

Dec 23, 2024

Dec 22, 2024

Here's Why Q32 Bio Stock Hit a New Record Low on Wednesday - MSN

Dec 22, 2024

Dec 21, 2024

Q32 Bio: Oppenheimer slashes price target on mixed trial results - MSN

Dec 21, 2024

Dec 17, 2024

Q32 Bio's SWOT analysis: stock outlook shifts amid clinical setbacks By Investing.com - Investing.com Canada

Dec 17, 2024

Dec 17, 2024

Q32 Bio's SWOT analysis: stock outlook shifts amid clinical setbacks - Investing.com India

Dec 17, 2024

Dec 16, 2024

Q32 Bio pushes back Phase 2 trial of ADX-097 in AAV patients - ANCA Vasculitis News

Dec 16, 2024

Dec 15, 2024

StockWatch: Q32 Shares Crater 85% as Investors, Analysts Sour on Trial Results - Genetic Engineering & Biotechnology News

Dec 15, 2024

Dec 15, 2024

BMO Capital Markets Cuts Q32 Bio (NASDAQ:QTTB) Price Target to $22.00 - Defense World

Dec 15, 2024

Dec 14, 2024

Q32 Bio FY2025 EPS Estimate Lifted by Leerink Partnrs - Defense World

Dec 14, 2024

Dec 13, 2024

FY2025 EPS Estimates for Q32 Bio Boosted by Leerink Partnrs - MarketBeat

Dec 13, 2024

Dec 12, 2024

Q32 Bio shares target cut, rating held on clinical trial results - Investing.com Canada

Dec 12, 2024

Dec 12, 2024

Here's Why Q32 Bio Stock Hit A New Record Low On Wednesday - Barchart

Dec 12, 2024

Dec 12, 2024

Q32 Bio (NASDAQ:QTTB) Rating Lowered to Hold at Leerink Partnrs - MarketBeat

Dec 12, 2024

Dec 12, 2024

Q32 Bio price target lowered to $20 from $80 at Oppenheimer - Yahoo Finance

Dec 12, 2024

Dec 11, 2024

Candel leads biotech gainers amid wave of data readouts - BioCentury

Dec 11, 2024

Dec 11, 2024

QTTB Stock Touches 52-Week Low at $8.06 Amid Market Volatility - Investing.com India

Dec 11, 2024

Dec 11, 2024

Leerink revises Q32 Bio stock target as Phase 2 trials fail to meet expectations - Investing.com Canada

Dec 11, 2024

Dec 11, 2024

Q32 Bio stock target cut, rating held on trial results By Investing.com - Investing.com Nigeria

Dec 11, 2024

Dec 11, 2024

Q32 Bio shares downgraded as Ph2 trials reveal limited near-term upside potential - Investing.com Nigeria

Dec 11, 2024

Dec 11, 2024

Q32 stock craters 71% on mixed Phase 2 data for bempikibart (NASDAQ:QTTB) - Seeking Alpha

Dec 11, 2024

Dec 11, 2024

Q32 Bio stock target cut, rating held on trial results - Investing.com

Dec 11, 2024

Dec 11, 2024

Oppenheimer maintains Outperform on Q32 Bio stock with focus on renal basket study - Investing.com

Dec 11, 2024

Dec 11, 2024

Why Is Skin Disease-Focused Q32 Bio Stock Trading Lower On Wednesday? - Benzinga

Dec 11, 2024